Professional Documents
Culture Documents
Phone: +91 79 26463394 | Email: Click here Enter Product Name or CAS No.
Advanced Search
Why Us (2R,3R)-3-(2,5-Difluorophenyl)-3-hydroxy-2-methyl-4-(1H-
1,2,4-triazol-1-yl)thiobutyramide (CAS No.: 368421-58-3)
Manus Aktteva Biopharma LLP is an ISO 9001:2015 Certified Global Supplier based in India for the product CAS No.: 368421-58-3.
We offer the product CAS No.: 368421-58-3 from our manufacturer / supplier / principals for your Research and Development /
Evaluation or Commercial requirements, based on the product's availability from our network. We can also offer other required
upstream or downstream intermediates with the supportive technical package for evaluation based on the customer's request.
We respect our customer's requirements of strict regulatory compliance and specification needs by offering the intermediates
Documentation Support transparently while offering easy access to manufacturer / supplier / principals with affordable and high-quality raw material
intermediates.
Technical Data package, CMC
If you are looking for any upstream or downstream intermediates concerning CAS No.: 368421-58-3, please feel free to email us.
data package & Drug master
files for most of the products as Based on your specific request, we will source the right manufacturer / supplier / principals who is reliable and meets your required
a part of our service quality standard requirements.
Queries
Properties Related API's
Click here
Material Safety Data Sheet Available on request
+91 79 26463394
+91 79 26463395
Products protected by valid patents from a manufacturer are not offered for sale in countries where the sale of such products
constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use from a manufacturer in accordance with 35 USC 271
+A13(1)
Products falling in to controlled substance category / list of schedule drugs shall be exported directly from the manufacturer
principals only against receipt of original import permission issued by concerned authorities of the importing country.
Manus Aktteva Biopharma LLP assumes no responsibility/liability in case of being imparted with goods which infringe intellectual
property in any manner whatsoever which includes patent rights of any individual manufacturer. Manus Aktteva makes no
representations or warranties of any kind, express or implied, about the originality or reliability with respect to the intellectual
property which includes patents of a manufacturer in its products or services for any purpose.
Manus Aktteva Biopharma LLP warns the sellers not to sell any goods which infringe intellectual property in any manner
whatsoever which includes patent rights of any individual or a manufacturer.
Manus Aktteva Biopharma LLP warns the buyers not to use/procure any goods from a manufacturer to achieve a product which
might be knowingly causing an infringement of intellectual property in any manner whatsoever which includes patent rights of
any individual manufacturer.
Manus Aktteva Biopharma LLP sources raw materials for intermediates for research & development purpose for (2R,3R)-3-(2,5-
Difluorophenyl)-3-hydroxy-2-methyl-4-(1H-1,2,4-triazol-1-yl)thiobutyramide (CAS No.: 368421-58-3) and can offer to
https://www.manusaktteva.com/intermediate/368421-58-3# 1/2
9/11/21, 8:14 AM 368421-58-3 | Manufacturers | Suppliers | India
pharmaceutical companies based in Afghanistan, Albania, Algeria, Andorra, Angola, Antigua and Barbuda, Argentina, Armenia,
Australia, Austria, Azerbaijan, Bahamas, Bahrain, Barbados, Belarus, Belgium, Belize, Benin, Bhutan, Bolivia, Bosnia and
Herzegovina, Botswana, Brazil, Brunei, Bulgaria, Burkina Faso, Burundi, Côte d'Ivoire, Cabo Verde, Cambodia, Cameroon,
Canada, Central African Republic, Chad, Chile, China, Colombia, Comoros, Congo (Congo-Brazzaville), Costa Rica, Croatia, Cyprus,
Czechia (Czech Republic), Democratic Republic of the Congo, Denmark, Djibouti, Dominica, Dominican Republic, Ecuador, Egypt,
El Salvador, Equatorial, Guinea, Eritrea, Estonia, Eswatini (fmr. "Swaziland"), Ethiopia, Fiji, Finland, France, Gabon, Gambia,
Georgia, Germany, Ghana, Greece, Grenada, Guatemala, Guinea, Guinea-Bissau, Guyana, Haiti, Holy See, Honduras, Hungary,
Iceland, India, Indonesia, Iraq, Ireland, Israel, Italy, Jamaica, Japan, Jordan, Kazakhstan, Kenya, Kiribati, Kuwait, Kyrgyzstan, Laos,
Latvia, Lebanon, Lesotho, Liberia, Libya, Liechtenstein, Lithuania, Luxembourg, Madagascar, Malawi, Malaysia, Maldives, Mali,
Malta, Marshall Islands, Mauritania, Mauritius, Mexico, Micronesia, Moldova, Monaco, Mongolia, Montenegro, Morocco,
Mozambique, Myanmar, Namibia, Nauru, Nepal, Netherlands, New Zealand, Nicaragua, Niger, Nigeria, North Macedonia,
Norway, Oman, Palau, Palestine State, Panama, Papua New Guinea, Paraguay, Peru, Philippines, Poland, Portugal, Qatar,
Romania, Russia, Rwanda, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Samoa, San Marino, Sao Tome
and Principe, Saudi Arabia, Senegal, Serbia, Seychelles, Sierra Leone, Singapore, Slovakia, Slovenia, Solomon Islands, Somalia,
South Africa, South Korea, Spain, Sri Lanka, Suriname, Sweden, Switzerland, Tajikistan, Tanzania, Thailand, Timor-Leste, Togo,
Tonga, Trinidad and Tobago, Tunisia, Turkey, Turkmenistan, Tuvalu, Uganda, Ukraine, United Arab Emirates, United Kingdom,
United States of America, Uruguay, Uzbekistan, Vanuatu, Vietnam, Yemen, Zambia & Zimbabwe.
This website is updated and maintained by Manus Aktteva Biopharma LLP. As a matter of policy, Manus Aktteva Biopharma LLP
does not entertain any anonymous or pseudonymous inquiries.
Privacy Policy & Disclaimer • News & Events • Logistics • Site Map Follow us on
© 2021 MANUS AKTTEVA BIOPHARMA LLP All rights reserved.
https://www.manusaktteva.com/intermediate/368421-58-3# 2/2